Hōʻike ʻia ka Galvus 500 ma nā puka papa no nā poʻe maʻi me nā maʻi koʻikoʻi o ka maʻi maʻi. ʻO ka lāʻau lapaʻau i nā hopena kīnā ʻaʻole e hopena i nā hopena hopena, akā, ʻaʻole pono ʻoe e hoʻohana i ka lāʻau lapaʻau inā ma nā liʻiliʻi liʻiliʻi me ka ʻole ke kauka ʻana a kauka i pale aku ai i nā hōʻeha.
Inoa Kūʻai ʻole honua
ʻO Vildagliptin + metformin - nā inoa o nā mea ikaika i ka lāʻau.
![](http://img.diabetesentity.com/img/sayd-2020/1221/500-19.png)
Hōʻike ʻia ka Galvus 500 ma nā puka papa no nā poʻe maʻi me nā maʻi koʻikoʻi o ka maʻi maʻi.
ATX
A10BH02 - pāʻālua no ka hoʻonaninani a me nā ʻano lāʻau ʻenehana.
E hoʻokuʻu i nā palapala a me ka ʻano
Loaʻa ka Galvus Met i ke ʻano o nā papa o 7 a 14 mau pcs. i loko o kahi pōpilikia.
Hoʻohana ʻia ka mea pono no ka hoʻohana pono ʻana.
ʻO ka ʻike o ka vildagliptin i 1 papa he 50 mg, a he metformin he 500 mg.
Ka hana lāʻau lapaʻau
Aia ka lāʻau lapaʻau i ka nui o nā mea kūmole hypoglycemic, ka mea e komo ai i nā 2 mau mea kaha i loaʻa nā ʻano hana like o ka hopena therapeutic. I ka manawa like, ʻo vildagliptin ka mea pale i ka dipeptidyl peptidase-4 (DPP-4), a me ke metformin hydrochloride e pili ana i ka hui o biguanides. I ka hui hoʻohui, ua mālama kēia mau mea i ka pae o ka glucose glucose i nā maʻi me ka maʻi ole e hoʻohana ai i ka diabetes mellitus (type 2) no 24 mau hola.
Hāʻawi ka papa ʻaina i ka hoʻohaʻahaʻa iki i ka hoʻoliʻiliʻi o ke kō, a me ke kūpaʻa ʻana o ka dinamics maikaʻi o nā hōʻailona haumania, ʻaʻohe liʻiliʻi nā maʻi o ka hoʻomohala ʻana i kahi ʻano pathological i hōʻike ʻia e ke kaila koko ma lalo o nā 3.5 mmol / l, ke koko peripheral ma lalo o kahi maʻamau (3.3 mmol / l) . ^ E Ha yM.
Lapaʻau lāʻau
ʻO kaʻai ʻana i kahi liʻiliʻi liʻiliʻi e hoʻopili i ka like ʻana o nā mea hana, akā ʻo ka hoʻokū ʻana o nā mea ikaika e hiki ʻole i kona kiʻekiʻe Inā ʻoe e lawe i ka pā ma ka ʻōpū ʻole, a ma hope o hoʻokahi hola, aia kahi kiʻekiʻe o nā mea ikaika i ka kaila koko.
![](http://img.diabetesentity.com/img/sayd-2020/1221/500-126.jpg)
Inā ʻoe e lawe i ka pā ma ka ʻōpū ʻole, a ma hope o hoʻokahi hola, aia kahi kiʻekiʻe o nā mea ikaika i ka kaila koko.
ʻO nā huahana decay i hoʻopau ʻia i ka urine a me kahi liʻiliʻi me nā feces. Ka bioavailability (ka hiki ke hoʻomau ʻia ka lāʻau) nā mea liʻiliʻi loa ma kahi o 80%.
Nā hōʻailona no ka hoʻohana ʻana
Hoʻoikaika ʻia ka lāʻau lapaʻau i loko o ia mau hihia:
- monotherapy me vildagliptin a metmorphine ʻaʻole i alakaʻi i ka hopena therapeutic makemake ʻia;
- hikiʻole i ka mālamaʻana i nā meaʻaiʻai i kahi kiʻi o ke kaupaona ʻana;
- Ka hopena i ka wā e hoʻāʻo ai e kaohi i ka glucose koko me nā koho lapaʻau ʻē aʻe.
Me ka type 1 diabetes mellitus, ʻaʻole i hoʻohana ʻia ka lāʻau lapaʻau.
Nā Hoʻohui
ʻAʻole hiki iā ʻoe ke hoʻohana i ka lāʻau lapaʻau i nā hihia.
- ka ahonui i kēlā me kēia mea ikaika;
- hana huehue o ke kino;
- ʻeha a me ka hoʻoweliweli ʻana o nā ʻano etiologies o kēlā me kēia ʻano;
- fiva
- ka haʻahaʻa hoʻemi haʻahaʻa haʻahaʻa i ke kino a i ʻole nā hui pilikino a me nā kiko;
- kahi ʻano maʻi iki o ka ʻāʻaka a me kahi ʻano hoʻowalewale o ke kino me ka waiʻona;
- ka hoʻomauʻana i ka pāʻai haʻahaʻa.
![](http://img.diabetesentity.com/img/sayd-2020/1221/500-128.jpg)
A ke ʻano maʻi o ka ʻaloʻaka he contraindication i ka hoʻohana ʻana i ka lāʻau lapaʻau.
Pehea e lawe ai iā Galvus 500
Pono nui e hahai i nā ʻōlelo aʻoaʻo no ka hoʻohana.
Me ka maʻi diabetes
Aia kekahi o ia mau hiʻohiʻona:
- Hoʻomoe ʻia ka nui o ka lāʻau lapaʻau e nā kauka hoʻokahi, ʻo ka nui o ka vildagliptin i hoʻohana ʻia ʻaʻole pono e oi aku i ka 0.1 g.
- I mea e pale aku ai i nā hopena ʻaoʻao, ʻoi aku ka maikaʻi o ka lāʻau lapaʻau me ka meaʻai.
- Hoʻomaka lākou me ka papa maʻi me ka papa papa 1 i ʻelua mau manawa i ka lā, a laila hiki ke hoʻonui ʻia ka hopena.
Nā hopena hopena o Galvus 500
Ma ka ʻāpana o ka io o ka hihiʻo
ʻOi paha ka emi ʻana o ka ʻike puʻupuʻu ʻike a me nā ʻano ʻē aʻe ʻē aʻe.
Mai ka musculoskeletal a me ka hoʻopili pili
Hoʻomaopopo ka ʻeha i nā ʻōpū.
![](http://img.diabetesentity.com/img/sayd-2020/1221/500-130.jpg)
![](http://img.diabetesentity.com/img/sayd-2020/1221/500-132.jpg)
![](http://img.diabetesentity.com/img/sayd-2020/1221/500-134.jpg)
![](http://img.diabetesentity.com/img/sayd-2020/1221/500-136.jpg)
![](http://img.diabetesentity.com/img/sayd-2020/1221/500-137.jpg)
![](http://img.diabetesentity.com/img/sayd-2020/1221/500-138.jpg)
![](http://img.diabetesentity.com/img/sayd-2020/1221/500-139.jpg)
ʻŌpala Gastrointestinal
ʻO ka manawa, hele ka maʻi ʻino, a hoʻopiʻi nā maʻi i ka luaʻi.
Hematopoietic mau hui
ʻAʻole ʻike pinepine ʻia nā hopena kūpono ʻole.
Pūnaehana pīhoihoi waena
Loaʻa pinepine nā hilahila a me ka haʻalulu o nā wāwae ma luna.
Mai ka pūnaehana urinary
Malia paha urination wikiwiki, ʻaʻole i hui pū ʻia e nā manaʻo hōʻeha.
Mai ka papa huhū
ʻAʻole i kākau ʻia ka huhū kaumaha.
Ma ka ʻāpana o ka ʻili
Hiki paha ke ʻano.
![](http://img.diabetesentity.com/img/sayd-2020/1221/500-147.jpg)
ʻO kekahi manawa, ʻoiai ke lawe nei i ka lāʻau, mālama ʻia ka moekolohe.
Mai ka pūnaehana genitourinary
ʻO ka manawa hele, ʻike ʻia ka impotence.
Mai ka pūnaehana cardiovascular
I kekahi manawa aia ka puʻuwai wikiwiki.
Allergies
Anaphylactic shock kekahi hiʻohiʻona no nā mea maʻi me ka hypersensitivity i nā mea hana ikaika.
Hoʻopilikia i ka hiki ke mālama i nā mīkini
Pono ʻoe e pale i ke kaʻa ʻana i ke kaʻa a me nā hana i pili i ka pili i ka piʻi ʻana o ka makaʻala.
Nā ʻōlelo kikoʻī
He mea nui e noʻonoʻo i nā hiʻohiʻona o ka hoʻohana ʻana i kēia lāʻau lapaʻau.
Hoʻohana i ka wā kahiko
ʻAʻole paipai ʻia e kuhikuhi i ka lāʻau lapaʻau i nā mea maʻi ma luna o 60 mau makahiki i ke koikoi lākou ma ka hana ma ke kahua hana, e like me aia nā hihia pinepine o ka lactic acidosis.
![](http://img.diabetesentity.com/img/sayd-2020/1221/500-148.jpg)
Contraindicated ka lāʻau ma nā kānaka ma lalo o 18 makahiki o kona mau makahiki.
Koha i na keiki
Mai hoʻohana i ka lāʻau lapaʻau no nā poʻe maʻi ma lalo o ka makahiki o ka hapa nui.
Hoʻohana i ka wā hāpai a me ka lactation
Ma nā hoʻokolohua hoʻokolohua, i ka wā i hoʻohana ʻia ai i nā dosis he 200 mau manawa i ʻoi aku i mua o ka mea i ʻōlelo ʻia ai, ʻaʻole i hoʻonā ka lāʻau i ka hoʻomōlohelohe i ka ulu ʻana a me ka hoʻomohala ʻana o ka embryo a ʻaʻole ia i hana i ka hopena teratogenic.
I ka wā hānai, ʻoi aku ka maikaʻi o ka hōʻole ʻana i ka mālama ʻana me Galvus.
Ke noi no ka hana renal haukapole
E hoʻohana me ka akahele inā he pilikia renal.
Hoʻohana no ka hana lawelawe lēwa
Pono ʻia ke hoʻoponopono ʻia.
ʻO ke kauā o Galvus 500
Inā nui ʻia ka nui o nā vildagliptin, ʻike ʻia ka ʻeha a me ke ʻala.
![](http://img.diabetesentity.com/img/sayd-2020/1221/500-149.jpg)
Me kahi overdose o ka metformin, hiki ke loaʻa ka nui o ke ea ma ke kino.
Me kahi overdose o ka metformin, nausea, ke nānā ʻana, a me ka hoʻohaʻahaʻa ʻana i ke ʻano o ke kino e hiki ai. Pono ke ʻano maʻi Symptomatic.
Hoʻopili pū me nā lāʻau ʻē aʻe
He mea nui e noʻonoʻo i nā mea aʻe:
- Me ka hoʻohana like ʻana o ka insulin, ʻo ka hala o ka haʻalele ʻana o Galvus ma muli o ka hiki ʻana o nā hopena ʻino e emi ana ma mua o 0,5% i ka hui vildagliptin, ʻoiai i ka hui plasebo ʻaʻohe mau mea e haʻalele ai i ka mālama ʻia.
- Me ka hui pū ʻana o Galvus a me nā lāʻau ʻē aʻe no ka mālama ʻana i nā maʻi maʻi type 2, ʻaʻohe hui pū ʻia o kahi maʻi lapaʻau.
- ʻO ka hoʻohanaʻana o ka furosemide e wikiwiki ai i ka hoʻopili ʻana o ka metformin.
- Hoʻopilikia ke diuretics a me nā kūmole waha i ka hopena o ka hopena therapeutic o kahi mākoki hypoglycemic.
- Pono ke ʻano Antipsychotic hoʻoponopono i ka hoʻoponopono a me ka kāohi o ke kaila o ke kō.
- ʻO ka hui pū me nā lau o ka radiopaque e noho nei ka mea hoʻonāukiuki i ka acidosis lactic a me ka holomua o ka renal dysfunction.
- Hoʻokomo i ka β2-sympathomimetics e hoʻonui i ka hoʻoliʻi koko ma ke ʻano o ka hōʻeuʻeu ʻana o nā ʻaeʻena β2.
Hoʻolaha ka waipuna
Hoʻohana ʻia ka hoʻohana ʻana i ka waiʻona e pale i ka hoʻonui ʻana i nā hopena o ka hopena.
![](http://img.diabetesentity.com/img/sayd-2020/1221/500-150.jpg)
Hoʻohana ʻia ka hoʻohana ʻana i ka waiʻona e pale i ka hoʻonui ʻana i nā hopena o ka hopena.
Nā kuʻina
ʻO ka hana kūpono a me ka palekana o ka hoʻohana ʻana, he ʻano like nō hoʻi o ka Glibomet a me Gluconorm.
Waihue huaʻōlelo waiho nā huaʻōlelo
Hiki iaʻu ke kūʻai me ke kī ʻole
ʻAe ʻia ia e kūʻai i ka lāʻau lapaʻau me ke ʻole o ka palapala.
Kūʻai
ʻO ka kumukūʻai o ka huahana ma kahi o 1200 mau rubles.
Ke waiho nei i nā kūlana no ka lāʻau lapaʻau
Hiki iā ʻoe ke mālama i ka lāʻau lapaʻau i ka mahana o ka lumi.
ʻO ka lā kau
Mālama ka lāʻau i kāna mau ho'ōlaola no 2 mau makahiki.
Mea hana
Kui ʻia ka huahana e ka hui Kelemania ʻo Novartis Pharma Production GmbH.
Hoike Mai
Kauka
Yuri, 43 makahiki, Moscow
E pale aku i ke ʻano o ka hoʻohana ʻana o Galvus, ua ʻike ʻia kahi lohi o nā lipids koko. I ka nui o nā manawa, kākau wau i ka lāʻau lapaʻau no nā poʻe maʻi me nā maʻi āpau hou, ʻoiai inā mākou e kamaʻilio e pili ana i nā wahine hāpai. E kōkua ka lāʻau lapaʻau e hoʻāla i ka maikaʻi i loko o 2 mau pule.
Oleg, 50 makahiki, Saint Petersburg
Pono mākou e kuhikuhi i nā mea kikowaena haʻahaʻa, no ka mea Ua kiʻekiʻe ke kumukūʻai o Galvus, ʻoiai ke kūpono. ʻOi aku koʻu makemake i ka hoʻomaʻemaʻe piha ʻana o ka maʻi, me ka pili ʻana i nā loina o ka papaʻai.
![](http://img.diabetesentity.com/img/sayd-2020/1221/500-20.png)
ʻAe ʻia ia e kūʻai i ka lāʻau lapaʻau me ke ʻole o ka palapala.
Na maʻi maʻi maʻi maʻi
Alla, 25 makahiki, Omsk
Nui wau i ka maʻalahi o ka hoʻohana ʻana i nā papa. Akā ua hālāwai wau i ka maʻi kaumaha a me ka luaʻi nui ʻana ma ka lā 3 o ka lawe ʻana i ka lāʻau lapaʻau. Ua ʻōlelo aku ke kauka ke hoʻomaha ʻana, a laila hoʻomau i ka mālama ʻana. Ua māʻona ʻo ka hopena o ka lāʻau maʻi.
Maxim, 40 makahiki, Perm
Ua lawe wau i ka pā hale no hoʻokahi mahina. Hola ka nui o ke kō kōʻai koko, a ʻike pū kekahi i ka hoʻemi ʻana o ke kaumaha o ke kino. Ua kāpae ke kauka i ke insulin i ka wā o ka maʻi me Galvus. ʻAʻole kūpono wale ke kumukūʻai o nā make, akā ʻaʻole lākou i manaʻo e lawe i ka hoʻohālikelike.